doi: 10.1001/jama.2022.6662.
First Donepezil Transdermal Patch Approved for Alzheimer Disease
- PMID: 35503362
- DOI: 10.1001/jama.2022.6662
Item in Clipboard
First Donepezil Transdermal Patch Approved for Alzheimer Disease
JAMA.
.
No abstract available
Similar articles
-
The donepezil transdermal system for the treatment of patients with mild, moderate, or severe Alzheimer's disease: a critical review.Expert Rev Neurother. 2024 Jun;24(6):607-614. doi: 10.1080/14737175.2024.2355981. Epub 2024 May 24. Expert Rev Neurother. 2024. PMID: 38785454 Review.
-
Brain injury, cognitive impairment, and donepezil.J Head Trauma Rehabil. 1999 Aug;14(4):424-7. doi: 10.1097/00001199-199908000-00010. J Head Trauma Rehabil. 1999. PMID: 10407214 No abstract available.
-
Another advertisement for donepezil.J Am Geriatr Soc. 2004 May;52(5):843; author reply 845-6. doi: 10.1111/j.1532-5415.2004.52230_1.x. J Am Geriatr Soc. 2004. PMID: 15086674 No abstract available.
-
Donepezil delay to nursing home placement study is flawed.J Am Geriatr Soc. 2004 May;52(5):845; author reply 845-6. doi: 10.1111/j.1532-5415.2004.52230_3.x. J Am Geriatr Soc. 2004. PMID: 15086676 No abstract available.
-
Pharmacologic management of Alzheimer disease.J Neurosci Nurs. 2008 Feb;40(1):55-9. doi: 10.1097/01376517-200802000-00009. J Neurosci Nurs. 2008. PMID: 18330411 Review.
Cited by
-
Intracalvariosseous administration of donepezil microspheres protects against cognitive impairment by virtue of long-lasting brain exposure in mice.Theranostics. 2024 Oct 14;14(17):6708-6725. doi: 10.7150/thno.100986. eCollection 2024. Theranostics. 2024. PMID: 39479440 Free PMC article.
-
Population Pharmacokinetic Modeling and Simulation for Dose Optimization of GB-5001, a Long-Acting Intramuscular Injection of Donepezil, in Healthy Participants.Neurol Ther. 2024 Oct;13(5):1453-1466. doi: 10.1007/s40120-024-00643-4. Epub 2024 Aug 10. Neurol Ther. 2024. PMID: 39126603 Free PMC article.
-
Donepezil combined with traditional Chinese medicine has promising efficacy on mild cognitive impairment: a systematic review and meta-analysis.Front Neurosci. 2023 Jul 5;17:1206491. doi: 10.3389/fnins.2023.1206491. eCollection 2023. Front Neurosci. 2023. PMID: 37476835 Free PMC article. Review.
-
In silico and in vitro analyses of a novel FoxO1 agonist reducing Aβ levels via downregulation of BACE1.CNS Neurosci Ther. 2024 Mar;30(3):e14140. doi: 10.1111/cns.14140. Epub 2023 Mar 9. CNS Neurosci Ther. 2024. PMID: 36892036 Free PMC article.
-
Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer's Drugs.Pharmaceutics. 2022 Oct 26;14(11):2296. doi: 10.3390/pharmaceutics14112296. Pharmaceutics. 2022. PMID: 36365114 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
